Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (27)
Matthew D. Galsky
Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
Begoña P. Valderrama
Hospital Universitario Virgen del Rocío, Seville, Spain
Marco Maruzzo
Istituto Oncologico Veneto (IOV)–IRCCS, Padua, Italy
Albert Font
Catalan Institute of Oncology Badalona, Badalona Applied Research Group in Oncology, Translational Program in Cancer Research, Institut Germans Trias i Pujol, Barcelona
Tudor Ciuleanu
Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania
Jonathan Chatzkel
University of Florida, Gainesville
Takuya Koie
Department of Urology, Gifu University Graduate School of Medicine, Gifu, Japan
Christopher J. Hoimes
Duke Cancer Institute, Duke University, Durham, NC
Javier Puente
Hospital Clínico Universitario San Carlos de Madrid, Madrid
Yousef Zakharia
Division of Hematology and Medical Oncology, Department of Internal Medicine Mayo Clinic Phoenix Arizona USA
Eli Rosenbaum
Rabin Medical Center, Davidoff Cancer Center, Petah Tikva, Israel
Katharina Boehm
University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany
Yohann Loriot
Université Paris-Saclay, Gustave Roussy, INSERM Unité Mixte de Recherche 981 — Prédicteurs Moléculaires et Nouvelles Cibles en Oncologie, Villejuif, France
Jens Bedke
Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart, Stuttgart, Germany
Thomas B. Powles
Barts Health NHS Trust, Barts Cancer Institute, Queen Mary University of London, London
Andrea Necchi
Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan Milan Italy
Pawel Wiechno
Klinika Nowotworów Układu Moczowego, Warsaw, Poland
Carlos Álvarez-Fernández
Hospital Universitario Central de Asturias, Oviedo, Spain
Tae-Hwan Kim
Pohang University of Science and Technology (POSTECH) , , 77 CheongamRo , , ,
Niara Oliveira
Mater Hospital Brisbane, Mater Misericordiae, Brisbane, QLD, Australia
Thomas W. Flaig
University of Colorado School of Medicine, Anschutz Medical Campus, Aurora
Heidi S. Wirtz
Pfizer, Bothell, WA
Michael Mihm
Astellas Pharma, Northbrook, IL
Qinlei Huang
Merck, Rahway, NJ
Aljosja Rogiers
Merck, Rahway, NJ
Blanca Homet Moreno
Merck, Rahway, NJ
Alfonso Gómez de Liaño
Complejo Hospitalario Universitario Insular–Materno Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain